Copper Oxodotreotide Cu-64: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Copper Oxodotreotide Cu-64. Educational only — not medical advice.
Labeled uses
Detectnet is indicated for use with positron emission tomography (PET) for localization of somatostatin receptor positive neuroendocrine tumors (NETs) in adult patients.
Source: FDA labeling via NIH DailyMed (set f898c8a7…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.